4//SEC Filing
Temperato John 4
Accession 0001551986-20-000308
CIK 0001551986other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:10 PM ET
Size
14.7 KB
Accession
0001551986-20-000308
Insider Transaction Report
Form 4
Temperato John
DirectorChief Executive Officer
Transactions
- Other
Stock Option (Right to Buy)
2020-11-27+639,655→ 639,655 totalExercise: $1.07Exp: 2030-11-27→ Common stock (639,655 underlying) - Other
Stock Option (Right to Buy)
2020-11-27+650,000→ 650,000 totalExercise: $1.07Exp: 2030-11-27→ Common stock (650,000 underlying) - Award
Common stock
2020-11-27+203,667→ 823,676 total - Other
Stock Option (Right to Buy)
2020-11-27−650,000→ 0 totalExercise: $0.62Exp: 2030-07-06→ Common stock (650,000 underlying) - Other
Stock Option (Right to Buy)
2020-11-27−639,655→ 310,345 totalExercise: $0.62Exp: 2030-07-06→ Common stock (639,655 underlying)
Footnotes (5)
- [F1]Represents restricted stock, all of which shall vest on November 27, 2021, contingent upon the Reporting Person's continued service with the Company through the vesting date.
- [F2]On November 27, 2020, the Company's Board of Directors approved a modification of the Reporting Person's option package. 650,000 options with an exercise price were cancelled and 650,000 options with an exercise price of $1.07 were reissued in its place.
- [F3]The option vest, if at all, upon satisfaction of certain performance criteria as determined by the Board in its discretion. Vesting will begin on the date the Board deems the performance criteria met (the "Performance Date"). Each performance tranche, consisting of 325,000 shares subject to the option, shall vest 25% on the one-year anniversary of the Performance Date with the remainder vesting monthly over 36 months following the Performance Date.
- [F4]On November 27, 2020, the Company's Board of Directors approved a modification of the Reporting Person's option package. 639,655 options with an exercise price of $0.6216 were cancelled and 639,655 options with an exercise price of $1.07 were reissued in its place.
- [F5]25% of these shares shall be deemed vested and exercisable on July 6, 2021 with the remainder vesting in equal monthly installments over the next 36 months, such that the option shall be fully vested on July 6, 2024, subject to the executive's continued service with the Company through each applicable vesting date.
Documents
Issuer
9 METERS BIOPHARMA, INC.
CIK 0001551986
Entity typeother
Related Parties
1- filerCIK 0001722407
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 4:10 PM ET
- Size
- 14.7 KB